Argan (AGX) has drawn fresh attention after recent share price moves, with the stock showing positive returns over the past month and past 3 months. This has prompted investors to reassess its current valuation and business profile.

The recent 7.3% 1 day share price return and 17.1% year to date share price return at a last close of $381.73 sit alongside a very large 1 year total shareholder return and an 8x 3 year total shareholder return. This points to strong momentum that has built over several years rather than just the past few weeks.

If Argan’s run has you thinking about what else is moving, it could be a good time to broaden your search with fast growing stocks with high insider ownership.

With Argan now trading at a last close of $381.73, ahead of the $361 analyst price target and sitting on very large multi year shareholder returns, you have to ask: is there still a buying opportunity here, or is the market already pricing in future growth?

Most Popular Narrative: 5.7% Overvalued

Argan’s most followed narrative puts fair value at $361.00, which sits below the recent $381.73 close. This means the current price is ahead of that framework.

Record backlog and continued project wins across gas, renewables, water treatment, and recycling plants provide multi-year revenue visibility, indicating potential for increased operating leverage and higher gross margins as larger projects are executed successfully.

Want to see what this backlog story is really pricing in? Revenue stepping up, margins holding a tighter range, and a richer earnings multiple. The exact mix might surprise you.

Result: Fair Value of $361.00 (OVERVALUED)

However, the story can change quickly if large gas projects in Texas are delayed, or if any major EPC contract runs into cost overruns or cancellation.

Build Your Own Argan Narrative

If you see the story differently or want to test your own assumptions against the same data, you can build a custom view of Argan in just a few minutes with Do it your way.

A great starting point for your Argan research is our analysis highlighting 2 key rewards and 1 important warning sign that could impact your investment decision.

Ready for more investment ideas?

If Argan has sharpened your focus, do not stop at one name. Broaden your watchlist now so you are not looking back wishing you had checked sooner.

• Spot potential value by scanning these 867 undervalued stocks based on cash flows that align with your view on cash flow strength and pricing.
• Tap into long term growth stories through these 13 dividend stocks with yields > 3% that combine income potential with business resilience.
• Get ahead of emerging themes by tracking these 19 cryptocurrency and blockchain stocks that are tied to blockchain and digital asset trends.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.